“The toxicology profile of evinacumab was evaluated in rats, monkeys and rabbits, which are pharmacologically relevant nonclinical species”
✓ VerifiedFDA pharmacology/toxicology review, p. 6Source ↗
Why that species
High sequence homology (83-98%) to human ANGPTL3 and evinacumab target binding in monkey, rabbit and rat
“The cynomolgus monkey, rabbit, and rat are pharmacologically relevant species for toxicologic evaluation of evinacumab considering the high sequence homology (83-98%) to human ANGPTL3 and evinacumab target binding data”
✓ VerifiedFDA pharmacology/toxicology review, p. 76Source ↗
Surrogate molecule
No surrogate; the clinical antibody was tested in rats, monkeys and rabbits
“The toxicology profile of evinacumab was evaluated in rats, monkeys and rabbits, which are pharmacologically relevant nonclinical species”
✓ VerifiedFDA pharmacology/toxicology review, p. 6Source ↗